1 completed, 1 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow SCHIZOPHRENIA 1 (Disorder): new trials by email Literature Review of SCHIZOPHRENIA 1 (Disorder) trials Research Report on SCHIZOPHRENIA 1 (Disorder)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia Xanomeline and trospium chloride (KarXT) - SCHIZOPHRENIA 1 (Disorder), Schizoaffecitve Disorder | Phase 1 / Phase 2 | Recruiting | New York State Psychiatric Institute | 12 | 2026-07-01 | 2026-07-14 |
| Bioequivalence Study to Compare Cariprazine 1.5 mg Hard Capsules (1.5 mg Cariprazine Hydrochloride) Versus Reagila® 1,5 mg Hartkapseln (Hard Capsules) (Cariprazine) Cariprazine Hard Capsules, Reagila® Hartkapseln (Hard Capsules) (Cariprazine) - SCHIZOPHRENIA 1 (Disorder) | Phase 1 | Completed | Humanis Saglık Anonim Sirketi | 32 | 2026-03-05 | 2026-07-08 |
cariprazine (1) · trospium chloride (1) · xanomeline (1)
Humanis Saglık Anonim Sirketi (1) · New York State Psychiatric Institute (1)
India (1) · United States (1)
Joshua T Kantrowitz, MD (1) · Ragy Girgis, MD (1)